20.1002.43% ( -0.500 )
Delay Closed: Nov 16, 16:08:11Profile
About

ALEBUND-B
09637.HK
Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong. Its products include AP301, a phosphate binder; AP306, a sodium-dependent phosphate transport protein inhibitor; one early-clinical-stage product candidate AP303; and four preclinical product candidates, including AP308, AP304, AP305, and AP307. Alebund Pharmaceuticals (Jiangsu) Limited was founded in 2018 and is headquartered in Yangzhou, China.
Profile
- Company Name
- Alebund Pharmaceuticals (Jiangsu) Limited
- Market
- SEHK
- Founded
- Industry
- --
- Fiscal Year End
- --
- Website
- www.alebund.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
